Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5. (Q37365473)
Jump to navigation
Jump to search
scientific article published on 27 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5. |
scientific article published on 27 July 2016 |
Statements
Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5 (English)
María García-Fernández
Agnieszka Checinska
Estela Cañón
Guadalupe T Calvo
Angel Colmenar
Luis Espinosa-Hevia
1 reference
1 reference
1 reference
1 reference